Tag Archive for: financing

In 2021, Metrion Biosciences moved into its labs in Cambridge, UK. © Metrion Biosciences Ltd

Cambridge-based Metrion Biosciences Ltd has secured £3.5m in new equity financing – led by Maven Capital Partners and a £1m contribution from existing investor, Gresham House Ventures.

Picture: © Cohesion Bureau

Continuing geopolitical uncertainty has perpetuated volatility in global markets, exacerbated by higher inflation and interest rates. The impact has left the biotech market in a limbo as investors eschew riskier investments, but there are signs of a potential recovery ahead.

Aerial view at EFPL where the technology was established. © EFPL

Lausanne-based Vandria SA has cashed in CHF18m in a Series A financing led by ND Capital to drive clinical development of VNA-318.

© Nature Design - pixabay.com

Antibiotics specialist Antabio SAS has raised €25m in a Series B financing round with subscriptions from the AMR Action Fund, the EIC Fund and from existing investors.

Carthera SA

Sorbonne University spin-out Carthera SA has closed its Series B financing round with an additional investment of €4.5m at €42m to launch clinical trials.
 

©UK.gov

On the occasion of SynbiTECH in London, British Science, Research and Innovation Minister, Andrew Griffith, unveiled a £2bn strategic 10-year plan to foster engineering biology.

© 18percentgrey - stock.adobe.com

Eligo Bioscience secures $30m in series B funding, advancing its innovative gene-editing solutions targeting diseases linked to bacterial genes within the human microbiome.

Cradle's team. © Cradle

Generative AI protein engineering specialist Cradle NV,  has raised US$24m in a Series A financing round led by Index Ventures w

Quotient Tx' co-founder Inigo Marincorena. © Onur Pinar /Wellcome Sanger Institute

Flagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at  cellular level with disease by Nanoseq, a sequencing method licenced from the Wellcome Sanger Institute.

© Solar Foods

Finnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein protein production and support the construction of a commercial production plant.